| Literature DB >> 19497744 |
Arjel D Bautista1, Olen M Stephens, Ligong Wang, Robert A Domaoal, Karen S Anderson, Alanna Schepartz.
Abstract
We recently reported a beta(3)-decapeptide, betaWWI-1, that binds a validated gp41 model in vitro and inhibits gp41-mediated fusion in cell culture. Here we report six analogs of betaWWI-1 containing a variety of non-natural side chains in place of the central tryptophan of the WWI-epitope. These analogs were compared on the basis of both gp41 affinity in vitro and fusion inibition in live, HIV-infected cells. One new beta(3)-peptide, betaWXI-a, offers a significantly improved CC(50)/EC(50) ratio in the live cell assay.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19497744 PMCID: PMC2737262 DOI: 10.1016/j.bmcl.2009.05.032
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823